| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.BJP.0704352 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Fsj.bjp.0704352 |
| https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1038/sj.bjp.0704352 | ||
| https://doi.org/10.1038/sj.bjp.0704352 | ||
| https://europepmc.org/articles/PMC1573044 | ||
| https://europepmc.org/articles/PMC1573044?pdf=render | ||
| P932 | PMC publication ID | 1573044 |
| P698 | PubMed publication ID | 11704641 |
| P5875 | ResearchGate publication ID | 11649546 |
| P50 | author | Stefania Gessi | Q91105158 |
| Stefania Merighi | Q91105161 | ||
| P2093 | author name string | P. A. Borea | |
| E. Leung | |||
| K. Varani | |||
| C. Ulouglu | |||
| E. Cattabriga | |||
| V. Iannotta | |||
| P2860 | cites work | Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects | Q22254619 |
| A physiological role of the adenosine A 3 receptor: Sustained cardioprotection | Q24650457 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Receptors for purines and pyrimidines | Q28283941 | ||
| Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells | Q28346734 | ||
| The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine | Q73470605 | ||
| Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors | Q28372041 | ||
| Activation of the A3 adenosine receptor affects cell cycle progression and cell growth | Q28374046 | ||
| [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors | Q28377523 | ||
| Metabolic and immunologic consequences of limited adenosine deaminase expression in mice | Q28589801 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| Dominance of G(s) in doubly G(s)/G(i)-coupled chimaeric A(1)/A(2A) adenosine receptors in HEK-293 cells | Q30306324 | ||
| A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. | Q30306595 | ||
| Adenosine and hemodialysis in humans. | Q32056614 | ||
| Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. | Q32065042 | ||
| Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells | Q32065053 | ||
| Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium | Q33802595 | ||
| A(2A) adenosine receptors in human peripheral blood cells | Q33849871 | ||
| Adenosine receptors and their ligands. | Q33927644 | ||
| Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications | Q33939663 | ||
| Structure and function of adenosine receptors and their genes. | Q34101838 | ||
| New potent and selective human adenosine A(3) receptor antagonists | Q34106706 | ||
| Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor | Q34124450 | ||
| Nomenclature and classification of purinoceptors. | Q34324355 | ||
| A role for central A3-adenosine receptors. Mediation of behavioral depressant effects | Q34871203 | ||
| Adenosine A3 receptors: novel ligands and paradoxical effects | Q35171034 | ||
| Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. | Q36008898 | ||
| Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors | Q36380776 | ||
| Signaling via A2A adenosine receptor in four PC12 cell clones | Q38328614 | ||
| Adenosine receptor subtypes: characterization and therapeutic regulation | Q40437012 | ||
| Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. | Q41056524 | ||
| Binding thermodynamics at A1 and A2A adenosine receptors | Q41187931 | ||
| [3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors | Q41493791 | ||
| Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes | Q41541156 | ||
| Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists | Q41818308 | ||
| Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 binding | Q43176977 | ||
| Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques | Q47999355 | ||
| Adenosine A3 receptor expression and function in eosinophils | Q48050447 | ||
| Enthalpy-entropy compensation in drug-receptor binding | Q60647187 | ||
| Adenosine receptors | Q70812922 | ||
| Mast cell degranulation following adenosine A3 receptor activation in rats | Q71627273 | ||
| G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain | Q71630622 | ||
| RNA analysis using miniprep RNA in reverse transcription PCR | Q71670235 | ||
| Adenosine stimulates proliferation of human endothelial cells in culture | Q72860000 | ||
| Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases | Q73019392 | ||
| Adenosine stimulation of DNA synthesis in human endothelial cells | Q73191415 | ||
| Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists | Q73223426 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| purinergic P1 receptor antagonists | Q50430421 | ||
| P304 | page(s) | 1215-26 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line | |
| P478 | volume | 134 |
| Q35556102 | A glance at adenosine receptors: novel target for antitumor therapy |
| Q39793029 | A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. |
| Q39418010 | A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy |
| Q44514698 | A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition |
| Q34159374 | A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation |
| Q40359398 | A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells |
| Q38886743 | Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3. |
| Q39373811 | Adenosine A1 receptors do not play a major role in the regulation of lipogenic gene expression in hepatocytes |
| Q39148961 | Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer. |
| Q37565200 | Adenosine receptors and cancer. |
| Q38121708 | Adenosine receptors as potential targets in melanoma |
| Q37645138 | Adenosine receptors: expression, function and regulation |
| Q40625492 | Adenosine stimulation of the proliferation of colorectal carcinoma cell lines. Roles of cell density and adenosine metabolism |
| Q39375802 | Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer |
| Q44643492 | Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields |
| Q42245878 | An in vivo model of melanoma: treatment with ATP. |
| Q41460345 | CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model |
| Q125860024 | Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology |
| Q125860025 | Cancer‐related somatic mutations alter adenosine A 1 receptor pharmacology—A focus on mutations in the loops and C‐terminus |
| Q94458590 | Characterization of cancer-related somatic mutations in the adenosine A2B receptor |
| Q40169268 | Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists |
| Q90447318 | Differential effect of adenosine on rhabdomyosarcoma migration and proliferation |
| Q52668077 | Discovery of benzothiazolylquinoline conjugates as novel human A3 receptor antagonists: biological evaluations and molecular docking studies. |
| Q33812773 | Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes |
| Q38907149 | Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues. |
| Q38915525 | Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts |
| Q35244188 | Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptor |
| Q38215678 | Immunoregulatory activity of adenosine and its role in human cancer progression |
| Q33606938 | Inosine Released from Dying or Dead Cells Stimulates Cell Proliferation via Adenosine Receptors |
| Q37135531 | Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A₃ adenosine receptor |
| Q36081682 | Molecular expression of adenosine receptors in OVCAR-3, Caov-4 and SKOV-3 human ovarian cancer cell lines |
| Q46026307 | Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives. |
| Q35788500 | Pharmacological and therapeutic effects of A3 adenosine receptor agonists |
| Q38765118 | Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging |
| Q91645307 | Prognostic Impact of Adenosine Receptor 2 (A2aR) and Programmed Cell Death Ligand 1 (PD-L1) Expression in Colorectal Cancer |
| Q37967105 | Purinergic signaling in healthy and diseased skin |
| Q24618782 | Purinergic signalling and cancer |
| Q40639053 | Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemotherapic drugs: taxol and vindesine |
| Q51809194 | Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors |
| Q40647461 | Recent developments in the field of A2A and A3 adenosine receptor antagonists |
| Q59171613 | Recent developments in the field of A3 adenosine receptor antagonists |
| Q60921609 | Targeting Adenosine Receptor Signaling in Cancer Immunotherapy |
| Q37957791 | The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches |
Search more.